Issue Date: February 29, 2016
ICIG will acquire Novartis drug plant
International Chemical Investors Group has agreed to acquire a Novartis enzyme-based fermentation products plant in Frankfurt. With the purchase, ICIG will become a major supplier of 7-aminocephalosporanic acid, an antibiotic intermediate. ICIG also plans to use the intermediate at its Latina, Italy, antibiotics plant. Since its inception in 2004, ICIG has acquired 24 chemical and drug businesses from major companies.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society